Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.17 USD
Change Today -0.0002 / -0.12%
Volume 303.0K
APHB On Other Exchanges
As of 3:43 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

ampliphi biosciences corp (APHB) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/31/14 - $0.34
52 Week Low
10/14/14 - $0.07
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

ampliphi biosciences corp (APHB) Related Businessweek News

No Related Businessweek News Found

ampliphi biosciences corp (APHB) Details

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the discovery, development, and commercialization of various bacteriophage therapeutics. The company’s lead programs include AmpliPhage-001 for the treatment of cystic fibrosis patients with P. aeruginosa lung infections; AmpliPhage-002 for the treatment of methicillin-resistant S. aureus infections; and AmpliPhage-004 for the treatment of C. difficile infections. It has a collaboration agreement with Intrexon Corporation to utilize synthetic biology platform for the identification, development, and production of bacteriophage-containing human therapeutics. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is headquartered in Glen Allen, Virginia.

18 Employees
Last Reported Date: 05/12/15
Founded in 1989

ampliphi biosciences corp (APHB) Top Compensated Officers

Interim Chief Financial Officer
Total Annual Compensation: $127.1K
Interim Chief Operating Officer and Director
Total Annual Compensation: $60.0K
Chief Scientific Officer
Total Annual Compensation: $225.5K
Compensation as of Fiscal Year 2014.

ampliphi biosciences corp (APHB) Key Developments

AmpliPhi Biosciences Corporation Proposes to Approve Amendments to its Articles of Incorporation

AmpliPhi Biosciences Corporation announced that at its AGM to be held on August 3, 2015, the company has proposed to approve amendment to its amended and restated Articles of Incorporation.

AmpliPhi Announces New Data Demonstrating Anti-Pseudomonal Bacteriophages Retained Biological Activity Following Nebulizationn

AmpliPhi BioSciences Corporation announced new data demonstrating that bacteriophages remain active against Pseudomonas aeruginosa(P. aeruginosa) after nebulization. Data from this study, performed in collaboration with the Royal Brompton Hospital and Imperial College, UK, were presented at the 38th European Cystic Fibrosis Conference, taking place in Brussels, Belgium. To determine if nebulization might provide a viable delivery option for AmpliPhage-001, AmpliPhi's program targeting P. aeruginosa infections in Cystic Fibrosis (CF) patients, researchers evaluated the biological activity of four different bacteriophages after nebulization through three commercially available nebulizers. Phages were collected downstream and their biological activity post-nebulization assessed in a standard plaque assay using two P. aeruginosa indicator strains. Phages exposed to non-functioning nebulizer chambers were used as controls. The results showed that all four anti-P. aeruginosa bacteriophages retained their biological activity through all of the nebulizers tested and minor titre drops were within variability of the methodology, confirming that this mode of administration may therefore be appropriate for future clinical trials.

AmpliPhi Biosciences Corporation - Shareholder/Analyst Call

Annual General Meeting


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
APHB:US $0.17 USD -0.0002

APHB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for APHB.
View Industry Companies

Industry Analysis


Industry Average

Valuation APHB Industry Range
Price/Earnings 3.0x
Price/Sales 88.7x
Price/Book NM Not Meaningful
Price/Cash Flow 2.4x
TEV/Sales 24.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMPLIPHI BIOSCIENCES CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at